Hymenochirin-1B [P5K]

General Information


DRACP ID  DRACP02299

Peptide Name   Hymenochirin-1B [P5K]

Sequence  IKLSKETKDNLKKVLKGAIKGAIAVAKMV

Sequence Length  29

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic (Derived from Hymenochirin-1B)

Type  Synthetic peptide

Classification

  

Active ACP Membrane lysis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma LC50=1.4 ± 0.2 μM CellTiter-Glo Luminescent Cell Viability assay 24 h 1
A549 Lung adenocarcinoma Carcinoma IC50=2.35±0.31 μM MTT assay 96 h 2
HCT 116 Colon carcinoma Carcinoma IC50=8.09±0.40 μM MTT assay 96 h 2
HepG2 Hepatoblastoma Blastoma IC50=4.28±0.38 μM MTT assay 96 h 2

Hemolytic Activity  Human erythrocytes: LC50=205 ± 15 μM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02299

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C140H256N38O37S

Absent amino acids  CFHPQRWY

Common amino acids  K

Mass  359551

Pl  11.02

Basic residues  8

Acidic residues  2

Hydrophobic residues  13

Net charge  6

Boman Index  -1943

Hydrophobicity  8.97

Aliphatic Index  124.48

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24185042

Title  Anti-tumor activities of the host-defense peptide hymenochirin-1B

Doi 10.1016/j.regpep.2013.10.006

Year  2013

Literature 2

Pubmed ID 30789695

Title  Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy

Doi 10.1021/acschembio.9b00046

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_4420

DRACP is developed by Dr.Zheng's team.